QQ客服 官方微博 反馈留言

	Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12-week, multicenter, randomized, double-masked, placebo-controlled phase III clinical study
	Chen Di; Zhang Shunhua; Bian Ailing; Hong Jing; Deng Yingping; Zhang Mingchang; Chen Wei; Shao Yan; Zhao Jialiang
	2019
卷号	98期号:31页码:e16710
ISSN号	1536-5964
DOI	10.1097/MD.0000000000016710
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6337920
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Chen Di,Zhang Shunhua,Bian Ailing,et al. Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12-week, multicenter, randomized, double-masked, placebo-controlled phase III clinical study[J],2019,98(31):e16710.
APA	Chen Di.,Zhang Shunhua.,Bian Ailing.,Hong Jing.,Deng Yingping.,...&Zhao Jialiang.(2019).Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12-week, multicenter, randomized, double-masked, placebo-controlled phase III clinical study.,98(31),e16710.
MLA	Chen Di,et al."Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12-week, multicenter, randomized, double-masked, placebo-controlled phase III clinical study".98.31(2019):e16710.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。